Infectious complications occurring in liver transplant recipients receiving mycophenolate mofetil

Abstract

Background. Mycophenolate mofetil (MMF) is a new immunosuppressive agent that is gaining widespread use in solid organ transplantation recipients. A comprehensive assessment of infectious complications after its use after liver transplantation has never been assessed

Similar works

Full text

thumbnail-image

UQ eSpace (University of Queensland)

redirect
Last time updated on 30/08/2013

This paper was published in UQ eSpace (University of Queensland).

Having an issue?

Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.